Literature DB >> 8341699

Rare scleroderma autoantibodies to the U11 small nuclear ribonucleoprotein and to the trimethylguanosine cap of U small nuclear RNAs.

A C Gilliam1, J A Steitz.   

Abstract

We have identified a scleroderma serum (Ru) with a previously undescribed specificity to protein components of the U11 small nuclear ribonucleoprotein particle (snRNP), a low-abundance member of the Sm class of U RNPs. The U11 RNP can be specifically immunoprecipitated from sonicated HeLa cells with Ru serum. In nuclear extracts, a fraction of the U11 particle is found complexed to the U12 RNP, an even lower abundance Sm snRNP. In glycerol gradient fractions, Ru serum identifies a 65-kDa protein that cosediments with the U11-U12 complex and is shifted upon targeted degradation of the U12 RNA. The 65-kDa protein therefore appears to be a component of the U11-U12 snRNP complex, whereas another Ru-reactive (140 kDa) protein may be associated with the free U11 RNP. The Ru serum also contains autoantibodies directed against the trimethylguanosine cap of U RNAs. This rare specificity has been described previously in only three other scleroderma patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8341699      PMCID: PMC47016          DOI: 10.1073/pnas.90.14.6781

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Transport of RNA between nucleus and cytoplasm.

Authors:  E Izaurralde; I W Mattaj
Journal:  Semin Cell Biol       Date:  1992-08

Review 2.  Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

3.  U2 as well as U1 small nuclear ribonucleoproteins are involved in premessenger RNA splicing.

Authors:  D L Black; B Chabot; J A Steitz
Journal:  Cell       Date:  1985-10       Impact factor: 41.582

4.  The U2 small nuclear ribonucleoprotein particle as an autoantigen. Analysis with sera from patients with overlap syndromes.

Authors:  J Craft; T Mimori; T L Olsen; J A Hardin
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

5.  Pre-mRNA splicing by complementation with purified human U1, U2, U4/U6 and U5 snRNPs.

Authors:  A R Krainer
Journal:  Nucleic Acids Res       Date:  1988-10-25       Impact factor: 16.971

Review 6.  Small nuclear RNAs in messenger RNA and ribosomal RNA processing.

Authors:  I W Mattaj; D Tollervey; B Séraphin
Journal:  FASEB J       Date:  1993-01       Impact factor: 5.191

7.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

8.  3' cleavage and polyadenylation of mRNA precursors in vitro requires a poly(A) polymerase, a cleavage factor, and a snRNP.

Authors:  G Christofori; W Keller
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

9.  A monoclonal antibody against 2,2,7-trimethylguanosine that reacts with intact, class U, small nuclear ribonucleoproteins as well as with 7-methylguanosine-capped RNAs.

Authors:  P Bochnig; R Reuter; P Bringmann; R Lührmann
Journal:  Eur J Biochem       Date:  1987-10-15

10.  Additional low-abundance human small nuclear ribonucleoproteins: U11, U12, etc.

Authors:  K A Montzka; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

View more
  11 in total

Review 1.  AT-AC pre-mRNA splicing mechanisms and conservation of minor introns in voltage-gated ion channel genes.

Authors:  Q Wu; A R Krainer
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

2.  The human 18S U11/U12 snRNP contains a set of novel proteins not found in the U2-dependent spliceosome.

Authors:  Cindy L Will; Claudia Schneider; Markus Hossbach; Henning Urlaub; Reinhard Rauhut; Sayda Elbashir; Thomas Tuschl; Reinhard Lührmann
Journal:  RNA       Date:  2004-06       Impact factor: 4.942

3.  Crystal structure of an RNA polymerase ribozyme in complex with an antibody fragment.

Authors:  Joseph A Piccirilli; Yelena Koldobskaya
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-27       Impact factor: 6.237

4.  Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis.

Authors:  Noreen Fertig; Robyn T Domsic; Tatiana Rodriguez-Reyna; Masataka Kuwana; Mary Lucas; Thomas A Medsger; Carol A Feghali-Bostwick
Journal:  Arthritis Rheum       Date:  2009-07-15

5.  Specific Recognition of a Single-Stranded RNA Sequence by a Synthetic Antibody Fragment.

Authors:  Yaming Shao; Hao Huang; Daoming Qin; Nan-Sheng Li; Akiko Koide; Jonathan P Staley; Shohei Koide; Anthony A Kossiakoff; Joseph A Piccirilli
Journal:  J Mol Biol       Date:  2016-09-02       Impact factor: 5.469

6.  Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.

Authors:  Ilaria Cavazzana; Tamara Vojinovic; Paolo Airo'; Micaela Fredi; Angela Ceribelli; Eleonora Pedretti; Maria Grazia Lazzaroni; Emirena Garrafa; Franco Franceschini
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-18       Impact factor: 8.667

7.  Synthetic antibodies for specific recognition and crystallization of structured RNA.

Authors:  Jing-Dong Ye; Valentina Tereshko; John K Frederiksen; Akiko Koide; Frederic A Fellouse; Sachdev S Sidhu; Shohei Koide; Anthony A Kossiakoff; Joseph A Piccirilli
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-27       Impact factor: 11.205

8.  SR protein splicing factors interact with the Rous sarcoma virus negative regulator of splicing element.

Authors:  L M McNally; M T McNally
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

9.  The SMN complex is associated with snRNPs throughout their cytoplasmic assembly pathway.

Authors:  Séverine Massenet; Livio Pellizzoni; Sergey Paushkin; Iain W Mattaj; Gideon Dreyfuss
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

10.  Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features.

Authors:  Rudolf Mierau; Pia Moinzadeh; Gabriela Riemekasten; Inga Melchers; Michael Meurer; Frank Reichenberger; Michael Buslau; Margitta Worm; Norbert Blank; Rüdiger Hein; Ulf Müller-Ladner; Annegret Kuhn; Cord Sunderkötter; Aaron Juche; Christiane Pfeiffer; Christoph Fiehn; Michael Sticherling; Percy Lehmann; Rudolf Stadler; Eckhard Schulze-Lohoff; Cornelia Seitz; Ivan Foeldvari; Thomas Krieg; Ekkehard Genth; Nicolas Hunzelmann
Journal:  Arthritis Res Ther       Date:  2011-10-21       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.